# Neo-TACE-HAIC for High-risk BCLC A Stage HCC (NeoconceptA)

> **NCT04777942** · NA · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 320 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** neo-TACE-HAIC+Surgery
- **PROCEDURE:** Surgery alone

## Key facts

- **NCT ID:** NCT04777942
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-02-20
- **Primary completion:** 2023-12-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2021-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04777942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04777942, "Neo-TACE-HAIC for High-risk BCLC A Stage HCC (NeoconceptA)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04777942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*